IGlycine CAS 56-40-6 kwiBakala lePharma (USP / EP / BP)
Ukusetyenziswa:
IGlycine (Isifinyezo seGly) yenye yee-amino acid ezingama-20. Isetyenziswa ngokubanzi kumayeza, amayeza kunye nokuqhutywa kokutya.
Njengokongezwa kokutya, ubukhulu becala isetyenziselwa ukunambitha, iswiti kunye nesongezelelo sesondlo. Yongezwa kwibhotolo, itshizi kunye imajarini ekwandiseni ubomi bokugcina.
Njengokongezwa kokutya, kongezwe kukutya ukonyusa ukuthanda ukutya kweenkukhu kunye nezilwanyana zasekhaya, ngakumbi izilwanyana zasekhaya.
Njengonyango oluphakathi lwamayeza, iGlycine isetyenziswa njengezinto ezingafunekiyo ze-cephalosporin, i-aureomycin buffer, i-VB6 kunye ne-Threonine njlnjl ne-thiamphenicol ephakathi. Xa i-Glycine isetyenziswa ngokudibeneyo ne-aspirin, inokunciphisa ukucaphuka esiswini. I-Glycine ikwasetyenziswa kwisisombululo senaliti ye-amino acid njengokufakwa kwesondlo.
IGlycine yeyona nto iphambili ekwenziweni kweGlyphosate yeyeza.
1. iTekhnoloji-yeBanga
(1) Isetyenziswa njengesinyibilikisi sokususa i-CO2 kwishishini lesichumiso, njengesongezo kwisisombululo se-galvanizing.
(2) Isetyenziswe njengomlawuli we-PH
(3) Isetyenziswa njengezinto eziphambili ezingafunekiyo zeHerbicide Glyphosate.
2. Ukutya / iBakala lokuTya
(1) Isetyenziswe njengokunambitheka, iswiti kunye nesongezelelo sesondlo. Ifakwe kwisiselo esinxilisayo, isilwanyana kunye nokulungiswa kokutya kwezityalo, ekwenzeni imifuno enetyiwa kunye nejem esimnandi.
(2) Njengesongezo sokwenza isosi enetyiwa, iviniga kunye nejusi yeziqhamo, ukulungiselela ukuphucula incasa kunye nencasa yokutya kunye nokonyusa isondlo sokutya.
(3) Njengokonga intlanzi kunye nejamu yamandongomane kunye nokuzinzisa ikrimu, itshizi njl.
(4) Njengearhente yokugcoba incasa yetyiwa etyiwayo kunye neviniga.
(5) Isetyenziswa njengesongezelelo sokondla ukonyusa iminqweno yeenkukhu kunye nezilwanyana zasekhaya, ngakumbi izilwanyana zasekhaya.
3.Ibanga lePharm
(1) Isetyenziswe kwisisombululo senaliti ye-amino acid njengokufakwa kwesondlo.
(2) Isetyenziswa njengeyeza elongezelelekileyo ukunyanga i-myasthenia eqhubekayo kunye ne-pseudo hypertrophic muscular dystrophy.
(3) Isetyenziswa njengearhente yokwenza iasidi ukunyanga i-neural hyperacidity kunye nesisu sesilonda esingaxhalanga.
Ukucaciswa
| INTO | EP7.0 | Iipilisi | I-USP39 | |
| Inkangeleko | Umgubo omhlophe wekristale | Umgubo omhlophe wekristale | - | |
| Ukubonakala kwesisombululo | kucace | kucace | - | |
| Uvavanyo lokuchonga (okokuqala A, okwesibini B, C) | A | Ukuya ku-S. | Ukuya ku-S. | - |
| B | Ukuya ku-S. | Ukuya ku-S. | ||
| C | Ukuya ku-S. | Ukuya ku-S. | ||
| Uvavanyo lokuchonga (uvavanyo lwee-infrared) | - | - | Ukuya ku-S. | |
| Izinto zeNinhydrin-positive | Ukuya ku-S. | - | Ukuya ku-S. | |
| Uvavanyo | 98.5-101.0% | 98.5-101.0% | 98.5-101.5% | |
| Ikloride | ≤0.0075% | ≤0.0075% | ≤0.007% | |
| Isinyithi esinzima (njenge-Pb) | 0.001% | 0.001% | ≤0.002% | |
| Sulphate | - | - | 0.0065% | |
| Ixabiso le-PH | 5.9 ukuya 6.4 | 5.9 ukuya 6.4 | - | |
| Ukuphulukana nokomisa | ≤0.5% | ≤0.5% | ≤0.2% | |
| Intsalela kwi ucinezelo | - | - | ≤0.1% | |
| Izinto ezinokusetyenziswa ngokulula | - | - | Ukuya ku-S. | |